LifeSiteNews.com

Wednesday January 22, 2003



     

CAMPAIGN LIFE COALITION SLAMS MANIPULATIVE LEGER POLL ON CLONING

Calls on federal government to drop Bill C-13

TORONTO, January 22, 2003 (LifeSiteNews.com) - The national pro-life organization Campaign Life Coalition, issued a press release today slamming the Canadian Press/Leger Marketing Poll which purportedly showed that 53% of Canadians were in favour of cloning embryos.

"The slant of the questions in this poll call for the responses given", said Jim Hughes, National President of Campaign Life Coalition. "Basically you are asking, are you in favour of cloning a human being which will be born or in favour of cloning a human being to steal their stem cells killing them in the process." "The second part of question one is deliberately deceitful. There has never been a clinic cure of anyone using embryonic stem cells, while the use of adult stem cell therapy has been very successful. Using the patient's own stem cells prevents rejection and the life-long use of costly anti-rejection drugs."

The organization also calls on the federal government to "drop Bill C-13 which will allow the use and killing of human embryos for research and will permit cloning. We call on people to call their MPs and tell them to vote against Bill C-13 when it is presented."

See the full press release at
http://www.lifesite.net/clc/press/2003/012203cloningpoll.htm or
http://www.lifesite.net/clc/press/2003/012203cloningpoll.pdf

Back to Top Back to Top


SHARE THIS STORY: E-mail  Print  Newsvine  Digg  Reddit  Del.icio.us  Facebook



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.